Clinical Trials Logo

Clinical Trial Summary

The study aims to explore the potential of combination therapy with fractional radiofrequency and topical tretinoin for treatment and overall improvement of striae albae. We also aim to assess subject satisfaction, local skin responses and adverse effects/reactions in relation to the treatments, alone and in combination.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05461755
Study type Interventional
Source Bispebjerg Hospital
Contact
Status Completed
Phase Phase 2
Start date November 22, 2022
Completion date July 5, 2023

See also
  Status Clinical Trial Phase
Completed NCT06000839 - A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology) N/A
Completed NCT02601105 - Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks N/A
Terminated NCT02452359 - Clinical Evaluation of Using Intense Pulsed Light for Improving the Appearance of Striae Distensae N/A
Recruiting NCT05827913 - Efficacy and Safety of Polylevolactic Acid Injection Combined With 1565nm Non-ablative Fractional Laser in the Treatment of Striae Distensae N/A
Completed NCT02126566 - Multiclear Treatment for Striae Distensae - A Pilot Study Phase 2
Completed NCT03858543 - Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae Early Phase 1
Completed NCT03390439 - Treatment of Atrofic Striae With Percutaneous Collagen Induction Therapy Versus Fractional Nonablative Laser N/A
Recruiting NCT04092881 - Efficacy of Short Pulsed 1064 nm Nd-YAG Laser Versus 10600 nm Fractional CO2 Laser in Treatment of Striae Alba N/A
Completed NCT02510768 - A Study to Evaluate the Efficacy of ELAPR in Women With Striae Distensae Alba Phase 1